|Podcasts|September 2, 2022

Lowering Lead Times, Controlling Costs, Retaining Talent

Author(s)Julian Upton

A look at the supply chain issues pertinent to the generics industry

Vincent Colicchio, vice president of supply chain and external manufacturing at Dr. Reddy's Laboratories, reviews the key supply chain advances in the course of his career and reflects on the particular demands of the COVID pandemic.

The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.

This podcast sponosored by LabVantage Soultions


Related to this article

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | © Tada Images - stock.adobe.com 521699065
In this week’s Pharma Pulse, the FDA launches a program that lets companies share its approval packages with foreign regulators, UPS agrees to acquire Australia and New Zealand health care courier Smartways Logistics and Cognizant introduces an AI-enabled patient hub offering.
CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.